Literature DB >> 17140260

Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation.

M E Hayes1, D C Drummond, K Hong, W W Zheng, V A Khorosheva, J A Cohen, Noble C O, J W Park, J D Marks, C C Benz, D B Kirpotin.   

Abstract

Genospheres are cationic lipid-nucleic acid nanoparticles prepared by the assembly of the lipids and nucleic acids from an aqueous/organic liquid monophase that independently dissolves the components, where the resultant particles are homogeneously sized (70-110 nm), with efficiently incorporated and protected DNA. In the present study, we demonstrate pH-dependent modulation of the Genosphere surface charge using pH-titratable lipids. By incorporation of the lipids with titratable anionic or imidazole headgroups, Genospheres with neutral or anionic surface charge at neutral pH were produced and compared for cellular uptake and transfection of a reporter gene (luciferase) in culture of breast cancer cells. The extent of particle-cell association was also studied by fluorescent microscopy and quantified by cytofluorometery. The effects of Genosphere surface modification with poly(ethylene glycol) (molecular weight 2000) at low (0.5 mol %) and high (5 mol %) grafting densities, as well as the effects of HER2-receptor-directed targeting by an internalizable anti-HER2 scFv F5, linked via PEG spacer, were also studied. Inclusion in the Genosphere formulation of pH-titratable lipids CHEMS (cholesteryl hemisuccinate), CHIM (1-(3-(cholesteryloxycarbonylamino)propyl)imidazole), or DSGG (1,2-distearoyl-sn-glycero-3-hemiglutarate) rendered the particles surface-charge neutral or slightly anionic at neutral pH, and cationic at mildly acidic pH, as shown by zeta-potential measurements. In HER2-targeted systems, transfection activity and target specificity with HER2-overexpressing SKBR-3 breast cancer cells were dependent on Genosphere surface charge and PEGylation. The highest target specificity correlated with low cationic charge at neutral pH, while incorporation of 5 mol % PEG-lipid had only minor effects on Genosphere-cell association, internalization, and transfection activity. The implications of this work for potential in vivo applications are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140260     DOI: 10.1021/mp060040v

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  19 in total

Review 1.  Selection and characterization of cell binding and internalizing phage antibodies.

Authors:  Yu Zhou; Lequn Zhao; James D Marks
Journal:  Arch Biochem Biophys       Date:  2012-05-22       Impact factor: 4.013

Review 2.  The role of HER2 in cancer therapy and targeted drug delivery.

Authors:  Wanyi Tai; Rubi Mahato; Kun Cheng
Journal:  J Control Release       Date:  2010-04-10       Impact factor: 9.776

3.  Discovery of internalizing antibodies to tumor antigens from phage libraries.

Authors:  Yu Zhou; James D Marks
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 4.  Development of recombinant cationic polymers for gene therapy research.

Authors:  Brenda F Canine; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2010-04-14       Impact factor: 15.470

5.  Very long chain N4, N9 -diacyl spermines: non-viral lipopolyamine vectors for efficient plasmid DNA and siRNA delivery.

Authors:  Hassan M Ghonaim; Shi Li; Ian S Blagbrough
Journal:  Pharm Res       Date:  2008-09-10       Impact factor: 4.200

Review 6.  Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.

Authors:  Lilian E van Vlerken; Tushar K Vyas; Mansoor M Amiji
Journal:  Pharm Res       Date:  2007-03-29       Impact factor: 4.200

7.  Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.

Authors:  Brenda F Canine; Yuhua Wang; Arash Hatefi
Journal:  J Control Release       Date:  2009-04-18       Impact factor: 9.776

8.  Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.

Authors:  J Graeme Hodgson; Ru-Fang Yeh; Amrita Ray; Nicholas J Wang; Ivan Smirnov; Mamie Yu; Sujatmi Hariono; Joachim Silber; Heidi S Feiler; Joe W Gray; Paul T Spellman; Scott R Vandenberg; Mitchel S Berger; C David James
Journal:  Neuro Oncol       Date:  2009-01-12       Impact factor: 12.300

Review 9.  microRNAs in gliomas: small regulators of a big problem.

Authors:  Joachim Silber; C David James; J Graeme Hodgson
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

10.  Expression of miR-124 inhibits growth of medulloblastoma cells.

Authors:  Joachim Silber; Rintaro Hashizume; Tristan Felix; Sujatmi Hariono; Mamie Yu; Mitchel S Berger; Jason T Huse; Scott R VandenBerg; C David James; J Graeme Hodgson; Nalin Gupta
Journal:  Neuro Oncol       Date:  2012-11-21       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.